Clinical Trial Update: Investigator Initiated Study to Assess the Efficacy of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease Following Photorefractive Keratectomy (PRK) [Phase 3]

View source ↗

Summary

Investigator-initiated Phase 3 trial evaluating OC-01 (varenicline) nasal spray for dry eye disease after PRK.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye

Drugs mentioned

• OC-01 (Varenicline) Nasal Spray (varenicline)

Snippet

Sponsor: Brandon Baartman | Conditions: Dry Eye | Phase 3 | Status: UNKNOWN